Page 31 - Hikma - Oncology booklet
P. 31
Indication
Treatment of multiple myeloma in combination with
Click to edit Master title style
dexamethasone.
Treatment of patients with transfusion-dependent anemia
due to low- or intermediate- risk myelodysplastic syndromes
Associated Conditions
01 Chronic Lymphocytic Leukemia (CLL)
02 Mantle Cell Lymphoma (MCL)
03 Multiple Myeloma (MM)
04 Myelodysplastic Syndrome
05 Light chain amyloidosis
06 Refractory Diffuse Large B Cell Lymphoma
Dosage
Myelodysplastic Disease:
10 mg Orally once a day
Lymphoma Disease:
Orally once a day on days 1 to 21
25 mg of repeated 28-day cycles.
18/01/2020 1
30
